Angel News

Angel News

Back to Homepage

1st July 2019

Vesalius Biocapital III closes €120 million fund

Vesalius Biocapital III, the specialist life sciences venture capital investor, has closed its VBC III fund securing EUR 120 million of equity commitments. This includes commitments of EUR 30 million from the European Investment Fund (EIF) and new and existing investors from Europe, the Americas and MENA. The fund is a validation of Vesalius’ proven approach to invest in later-stage European life sciences companies, providing capital to support their development. Vesalius Biocapital III has executed three investments to date.

1st July 2019

Foresight invests £4 million growth capital into Ten Health & Fitness

Foresight Group LLP has announced a £4 million growth capital investment into Ten Health and Fitness Limited, a fast-growing provider of health and fitness services in London. 

25th June 2019

Fertility startup  Dr Fertility raises £1 million seed funding

North West-focused Praetura Ventures has backed fertility startup Dr Fertility in a £1m seed round. The first investment of Praetura’s maiden EIS Fund will be used to develop Dr Fertility into a full-service digital health platform.  Founded by Dr Lucy Buckley, PhD and Kobi McCardle in June 2018, Dr Fertility was created to address the problem of conflicting, unreliable information about fertility. With patients having to wait up to two years between GP advice and the first outpatient appointment, and no central, official platform for fertility advice, Lucy and Kobi saw the need to support the 1 in 7 couples in the UK that are affected by infertility. 

 

19th June 2019

Digital wellbeing platform hero raises £1.3 million

hero, a health tech and wellbeing strategy provider formed to have a positive influence on individuals, organisations and communities by supporting proactive wellness across all areas of physical, mental and financial health, has closed its latest funding round, raising over £1.3 million to tackle these issues head on.  

Having already established itself in the workplace and developer markets and the professional sports sector, hero works with over 100 clients across the UK including names like the NHS, HSBC, Legal and General, Caddick Construction and Inspired Villages. hero has developed and launched a unique digital platform - Navigator to enable employers and organisation to create a full service solution to deliver preventive and personalised experiences for end users.  

5th June 2019

Downing leads £1.5m investment in The Electrospinning Company

Downing Ventures has led a £1.5 million funding in The Electrospinning Company, alongside VC firm MidVen, Newable Private Investing and the STFC.

 

29th May 2019

Seventure Partners renews support to Domain Therapeutics and invests €3.5M

Domain Therapeutics has announced that it has secured a €3.5M ($3.9M) investment from existing shareholder Seventure Partners, to accelerate its next growth phase. 

23rd May 2019

Syncona founds Quell Therapeutics with £35 million investment

Syncona Ltd has founded Quell Therapeutics, a new cell therapy company, with a £35 million commitment in a Series A financing of which Syncona has committed £34.0 million with a further £1.0 million being contributed by UCL Technology Fund. Syncona will have a 69.3 per cent stake (1) in the business, with the first tranche of the Series A commitment of £8.3m paid in May 2019.


23rd May 2019

PBD Biotech appoints new CEO

Angel backed novel diagnostic developer PBD Biotech has appointed new CEO Mark Hammond to drive the company’s expansion. 

20th May 2019

Catalan biomedical companies attracted €106 million in 2018 for new drugs and technology

The global biomedical market is in the midst of a period of stable growth and Catalonia, one of the most dynamic healthcare hubs in the world, is also enjoying this trend. 2018 was a positive year for the Catalan biomedical business fabric, in terms of funding, R&D alliances and advances, and launching new drugs and medical technology.

1st May 2019

Bowmark sells CARE Fertility to Silverfleet Capital

Bowmark Capital, the mid-market private equity firm, has agreed to sell CARE Fertility, the UK’s leading fertility clinic group for IVF treatment, to Silverfleet Capital.

29th April 2019

 EMV Capital invests in liquid biopsy company Vortex Biosciences

EMV Capital has acquired a controlling stake in Bay Area-based Vortex Biosciences, and a further investment package to accelerate the company’s development.

18th April 2019

Touch Biometrix secures £2 m funding from Deepbridge

Touch Biometrix has received a £2million investment from Deepbridge Capital.

The Series A funding through the Deepbridge Technology Growth Enterprise Investment Scheme (EIS) fund follows initial seed funding of £150,000 last year.

North Wales based Touch Biometrix is developing a new class of fingerprint sensor for application to consumer electronics such as smartphones and laptops.

PREVIOUSItems 24 of 165NEXT

Back to Homepage